Trial intelligence / Profile preview

Pre-operative Chemo-radiotherapy vs Chemotherapy in PET Non-Responder Esophageal Cancer

NCT01608464Phase 2Terminated

Sponsor
King Faisal Specialist Hospital and Research Centre
Start
May 2012
Primary completion
Sep 2015
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Cisplatin micelle injection (HA132), fluorouracil in esophageal carcinoma, sponsored by King Faisal Specialist Hospital and Research Centre. Started May 2012; status: terminated.

02

Drugs

Cisplatin micelle injection (HA132)fluorouracil
03

Conditions

esophageal carcinoma

Beyond the preview

Go deeper on NCT01608464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01608464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call